Prothena Corp plc (36)

Browse by Contract Category

Contracts

Third Amendment to the Prothena Corporation plc 2018 Long Term Incentive Plan (Filed With SEC on May 20, 2022)
Description of Registrants Securities (Filed With SEC on February 25, 2022)
Distribution Agreement, dated December 23 2021, by and among the Company, Piper Sandler & Co., Stifel, Nicolaus & Company, Incorporated, Cantor Fitzgerald & Co., RBC Capital... (Filed With SEC on December 23, 2021)
Amendment No. 2 to License, Development, and Commercialization Agreement, entered into on December 11, 2013, among Prothena Biosciences Limited, Prothena Biosciences Inc, F.... (Filed With SEC on November 4, 2021)
Share Purchase Agreement, dated as of July 8, 2021, by and among Novo Nordisk A/S, Novo Nordisk Region Europe A/S, Prothena Corporation plc, and Prothena Biosciences Limited (Filed With SEC on November 4, 2021)
First through Eleventh Amendments to the Prothena Corporation plc 2020 Employment Inducement Incentive Plan (Filed With SEC on February 25, 2022)
Tenth Amendment to the Prothena Corporation plc 2020 Employment Inducement Incentive Plan (Filed With SEC on November 4, 2021)
Amended and Restated Consulting Agreement, dated July 15, 2020, between Prothena Biosciences Inc and Dennis J. Selkoe (Filed With SEC on November 4, 2021)
U.S. License Agreement, dated as of July 30, 2021, as amended on August 12, 2021 and September 8, 2021, by and between Prothena Biosciences Limited and Celgene Switzerland LLC (Filed With SEC on November 4, 2021)
Ninth Amendment to the Prothena Corporation plc 2020 Employment Inducement Incentive Plan (Filed With SEC on August 5, 2021)
Eighth Amendment to the Prothena Corporation plc 2020 Employment Inducement Incentive Plan (Filed With SEC on August 5, 2021)
Distribution Agreement, dated May 28, 2021, by and among the Company, Piper Sandler & Co., Stifel, Nicolaus & Company, Incorporated, Cantor Fitzgerald & Co., RBC Capital Markets,... (Filed With SEC on May 28, 2021)
Second Amendment to the Prothena Corporation plc 2018 Long Term Incentive Plan (Filed With SEC on May 21, 2021)
Seventh Amendment to the Prothena Corporation plc 2020 Employment Inducement Incentive Plan (Filed With SEC on May 11, 2021)
Offer Letter, dated March 18, 2021, between Prothena Biosciences Inc and Hideki Garren (Filed With SEC on May 11, 2021)
Underwriting Agreement, dated March 23, 2021, by and among Prothena Corporation plc and Citigroup Global Markets Inc., Jefferies LLC, and Cantor Fitzgerald & Co (Filed With SEC on March 26, 2021)
Consulting Agreement, dated July 15, 2020, between Prothena Biosciences Inc and Dennis J. Selkoe (Filed With SEC on February 26, 2021)
First through Sixth Amendments to the Prothena Corporation plc 2020 Employment Inducement Incentive Plan (Filed With SEC on February 26, 2021)
Description of Registrants Securities (Filed With SEC on February 26, 2021)
Third Amendment to the Prothena Corporation plc 2020 Employment Inducement Incentive Plan (Filed With SEC on November 4, 2020)
Form of Option Award Agreement (Filed With SEC on August 6, 2020)
First Amendment to the (Filed With SEC on August 6, 2020)
First Amendment to the Prothena Corporation plc 2018 Long Term Incentive Plan (Filed With SEC on May 22, 2020)
Prothena Corporation plc 2020 Employment Inducement Incentive Plan (Filed With SEC on May 6, 2020)
License Agreement, dated as of March 1, 2020, between Prothena Biosciences Limited and F. Hoffmann-La Roche Ltd (Filed With SEC on May 6, 2020)
Understanding Related to License, Development, and Commercialization Agreement, dated as of March 1, 2020, among Prothena Biosciences Limited, Prothena Biosciences Inc, F.... (Filed With SEC on May 6, 2020)
Option Award Agreement, dated March 2, 2020, between Prothena Corporation plc and Brandon S. Smith under the Prothena Corporation plc 2020 Employment Inducement Incentive Plan (Filed With SEC on May 6, 2020)
Offer Letter, dated February 18, 2020, between Prothena Biosciences Inc and Brandon S. Smith (Filed With SEC on May 6, 2020)
Engagement Agreement, dated October 2, 2019, between Prothena Biosciences Inc and A. W. Homan (Filed With SEC on March 3, 2020)
Release Agreement, dated October 1, 2019, between Prothena Biosciences Inc and A. W. Homan (Filed With SEC on March 3, 2020)
Amendment to License, Development, and Commercialization Agreement, entered into on October 1, 2019, among Prothena Biosciences Limited, Prothena Biosciences Inc, F. Hoffman-La... (Filed With SEC on March 3, 2020)
Consulting Agreement, dated July 1, 2019, between Prothena Biosciences Inc and Dennis J. Selkoe (Filed With SEC on November 5, 2019)
Amended and restated retirement transition letter, dated July 1, 2019, between Prothena Biosciences Inc and A.W. Homan (Filed With SEC on November 5, 2019)
Offer letter, dated June 4, 2019, between Prothena Biosciences Inc and Michael J. Malecek (Filed With SEC on August 6, 2019)
Promotion letter, dated December 11, 2018, between Prothena Biosciences Inc and Radhika Tripuraneni (Filed With SEC on March 15, 2019)
Retirement transition letter, dated December 11, 2018, between Prothena Biosciences Inc and A. W. Homan (Filed With SEC on March 15, 2019)